XENT
Intersect ENT, Inc
XENT
XENT
Delisted
XENT was delisted on the 12th of May, 2022.
103 hedge funds and large institutions have $247M invested in Intersect ENT, Inc in 2016 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 31 increasing their positions, 32 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
28% less capital invested
Capital invested by funds: $343M → $247M (-$96.6M)
86% less call options, than puts
Call options by funds: $645K | Put options by funds: $4.53M
Holders
103
Holding in Top 10
1
Calls
$645K
Puts
$4.53M
Top Buyers
| 1 | +$7.15M | |
| 2 | +$6.44M | |
| 3 | +$4.69M | |
| 4 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$4.44M |
| 5 |
Barclays
London,
United Kingdom
|
+$3.59M |
Top Sellers
| 1 | -$12.1M | |
| 2 | -$10.1M | |
| 3 | -$7.13M | |
| 4 |
UBS AM
Chicago,
Illinois
|
-$6.47M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$6.19M |